Skip to content

    LEXICON PHARMACEUTICALS (LXRX) stock price & financials

    View LXRX earnings calls

    Overview

    Price

    Market Cap

    Sector

    Rank

    Performance+102.7% 1Y

    Financials

    Income Statement

    Financial Trajectories

    11
    Quarterly
    MetricQ3 FY24Q4 FY24Q1 FY25Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Trend
    EarningsRevenue
    $1.75M
    $26.55M
    $1.26M
    $28.87M
    $14.18M
    +710.4%
    $5.49M
    -79.3%
    $21.10M
    +1572.1%
    $692.0K
    -97.6%
    Strengthening
    Operating Profit
    -$63.69M
    -$32.74M
    -$25.68M
    $3.74M
    -$12.19M
    +80.9%
    -$14.78M
    +54.8%
    -$996.0K
    +96.1%
    -$26.54M
    -810.4%
    Weakening
    Net Profit
    -$64.81M
    -$33.77M
    -$25.30M
    $3.25M
    -$12.77M
    +80.3%
    -$15.53M
    +54.0%
    -$1.04M
    +95.9%
    -$31.77M
    -1077.1%
    Weakening
    EPS
    $-0.18
    $-0.07
    $0.01
    $-0.04
    +77.8%
    $0.00
    +100.0%
    $-0.07
    -800.0%
    Weakening
    Other Income
    Interest
    Depreciation
    Profit before Tax
    MarginsOPM
    -3639.6%
    -123.3%
    -2034.8%
    12.9%
    -85.9%
    +97.6%
    -269.1%
    -118.3%
    -4.7%
    +99.8%
    -3835.3%
    -29738.8%
    Weakening
    Tax
    ReturnsROIC
    3.2%
    1.6%
    1.2%
    -0.2%
    0.6%
    -80.3%
    0.8%
    -54.0%
    0.1%
    -95.9%
    1.6%
    Weakening

    Balance Sheet

    Balance Sheet

    USD · Annual
    Line itemFY18FY19FY20FY21FY22FY23FY24FY25TTM
    AssetsCash & Equivalents$80.39M$36.11M$126.26M$64.06M$46.34M$22.46M$66.66M$34.33M$40.92M
    Short-Term Investments
    Total Current Assets$173.32M$337.75M$157.72M$88.92M$140.87M$176.55M$246.19M$101.89M$196.58M
    Net PP&E$15.87M$15.85M$295.0K$3.48M$8.48M$7.51M$7.32M$9.18M$8.57M
    Goodwill$44.54M$44.54M$44.54M$44.54M$44.54M$44.54M$44.54M$44.54M$44.54M
    Intangibles$50.12M$19.72M
    Total Assets$284.14M$417.71M$203.79M$136.91M$194.30M$229.43M$298.42M$184.99M$250.06M
    LiabilitiesTotal Current Liabilities$36.75M$65.34M$46.81M$22.12M$23.17M$31.55M$45.25M$20.87M$14.71M
    Short-Term Debt$1.11M$11.01M$11.65M$0$0$4.59M$0
    Long-Term Debt$243.89M$234.17M$0$0$48.58M$99.51M$100.30M$49.41M$51.44M
    Long-Term Leases$5.42M$5.30M$4.60M$6.60M$6.16M
    Total Liabilities$310.54M$300.61M$47.42M$23.31M$77.17M$136.32M$152.47M$77.45M$75.53M
    EquityCommon Stock & APIC$106.0K$106.0K$142.0K$150.0K$189.0K$245.0K$363.0K$366.0K$447.0K
    Retained Earnings-$1.47B-$1.34B-$1.40B-$1.49B-$1.59B-$1.77B-$1.97B-$2.02B-$2.05B
    Total Equity-$26.41M$117.10M$156.37M$113.59M$117.12M$93.11M$145.95M$107.54M$174.53M
    HighlightsNet Cash / (Debt)-$164.62M-$209.07M$114.62M$64.06M-$33.64M-$19.68M-$10.51M

    Cash Flow

    Cash Flow

    USD · Annual
    Line itemFY18FY19FY20FY21FY22FY23FY24FY25TTM
    ActivitiesCash from Operating-$148.61M$113.81M-$142.97M-$87.02M-$88.85M-$161.90M-$178.78M-$67.85M-$64.99M
    Cash from Investing$169.58M-$155.85M$380.76M$2.11M-$71.08M-$49.94M-$15.38M$113.02M-$29.77M
    Cash from Financing-$2.24M-$2.23M-$147.64M$22.71M$142.21M$187.96M$238.35M-$48.50M$85.32M
    SummaryCapital Expenditure-$95.0K-$70.0K-$87.0K-$1.22M-$1.33M-$470.0K-$1.03M$0
    Free Cash Flow-$148.70M$113.74M-$143.06M-$88.24M-$90.18M-$162.37M-$179.81M-$67.85M
    FCF Margin-235.3%35.3%-596.2%-29610.1%-64875.5%-13485.6%-578.5%-136.2%

    Ratios